Browsing: dermatology research

AAD 2026: Late-Breaking Data Demonstrate Efficacy of Nemolizumab in Children (Aged 2-11) with Moderate-to-Severe Atopic Dermatitis

By Marie ChenApril 13, 20260

New phase II data suggest nemolizumab may reduce itch and skin lesions in children aged 2 to 11 with moderate-to-severe atopic dermatitis.

About
Advertise
Contact Us
Privacy Policy

About
Advertise
Contact Us
Privacy Policy

Copyright © Medical Channel Asia 2024. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

What's Hot

Runner’s Diarrhoea: The Race-Day Problem Nobody Wants to Discuss

The Haze Returns With More Than Just A Cough

Beyond 10,000 Steps, Make Time for Strength Training Too

Browsing: dermatology research

AAD 2026: Late-Breaking Data Demonstrate Efficacy of Nemolizumab in Children (Aged 2-11) with Moderate-to-Severe Atopic Dermatitis

Runner’s Diarrhoea: The Race-Day Problem Nobody Wants to Discuss

The Haze Returns With More Than Just A Cough

Beyond 10,000 Steps, Make Time for Strength Training Too

Half of Singapore Workers Surveyed Think Daytime Sleepiness Is Normal

Subscribe to Updates

What's Hot

Browsing: dermatology research

Subscribe to Updates